Beta interferons in clinically isolated syndromes: a meta-analysis Interferons beta nas síndromes clínicas isoladas: meta-análise
Beta-interferon use in definite multiple sclerosis (MS) has been proven to modify clinical and magnetic resonance imaging outcome. We review and summarize the data of published double-blind, randomized clinical trials to assess, with a meta-analysis the safety and efficacy of beta-interferon on the...
Main Authors: | Ailton Melo, Bernardo Rodrigues, Amit Bar-Or |
---|---|
Format: | Article |
Language: | English |
Published: |
Academia Brasileira de Neurologia (ABNEURO)
2008-03-01
|
Series: | Arquivos de Neuro-Psiquiatria |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2008000100003 |
Similar Items
-
Clinical response to interferon beta and glatiramer acetate in multiple sclerosis patients: a Brazilian cohort
by: Valéria Coelho Santa Rita Pereira, et al.
Published: (2012-10-01) -
Erupção acneiforme aguda induzida por interferon beta-1b durante tratamento para esclerose múltipla Acute acneiform eruption induced by interferon beta-1b during treatment for multiple sclerosis
by: Dário Júnior de Freitas Rosa, et al.
Published: (2011-04-01) -
Anxiety and depressive symptoms in clinically isolated syndrome and multiple sclerosis
by: Carolina Fiorin Anhoque, et al.
Published: (2011-12-01) -
Tratamento de esclerose múltipla com interferon β-1A
by: Paulo Henrique Pires de Aguiar, et al.
Published: (2018-11-01) -
Classical immunomodulatory therapy in multiple sclerosis: how it acts, how it works
by: Amélia Mendes, et al.
Published: (2011-06-01)